CA
TWST icon

Clearstead Advisors’s Twist Bioscience TWST Stock Holding History

Clearstead Advisors’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.1M Buy
107,303
+99,290
+1,239% +$4.45M 0.05% 233
2025
Q4 		$254K Buy
8,013
+7,986
+29,578% +$249K ﹤0.01% 865
2025
Q3 		$760 Buy
+27
New +$818 ﹤0.01% 2665
2025
Q1 		– Sell
-17
Closed -$790 – 2313
2024
Q4 		$790 Buy
+17
New +$768 ﹤0.01% 1945
2021
Q4 		– Sell
-100
Closed -$11K – 1435
2021
Q3 		$11K Hold
100
– – ﹤0.01% 935
2021
Q2 		$13K Hold
100
– – ﹤0.01% 769
2021
Q1 		$12K Hold
100
– – ﹤0.01% 756
2020
Q4 		$14K Hold
100
– – ﹤0.01% 675
2020
Q3 		$8K Buy
+100
New +$6.23K ﹤0.01% 702

Other funds holding TWST

Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Clearstead Advisors's TWST Position: Q1 2026 in Review

Clearstead Advisors increased its Twist Bioscience (TWST) stake by 1,239% in Q1 2026, buying an estimated $4.45M and bringing the position to 107,303 shares worth $5.1M. The position accounts for 0.05% of the portfolio, ranked #233.

Clearstead Advisors first reported a position in TWST in Q3 2020 and has held it in 9 quarters since. 279 funds tracked by Wall St. Rank hold TWST as of Q1 2026.

  • Clearstead Advisors held 107,303 shares of Twist Bioscience worth $5.1M as of Q1 2026.
  • Clearstead Advisors bought 99,290 Twist Bioscience shares in Q1 2026, an estimated $4.45M.
  • Twist Bioscience made up 0.05% of Clearstead Advisors's portfolio in Q1 2026, its #233 holding.
  • Clearstead Advisors first reported a position in Twist Bioscience in Q3 2020 and has held it in 9 quarters since.
  • 279 funds tracked by Wall St. Rank held Twist Bioscience as of Q1 2026.

Based on Clearstead Advisors's 13F filing for Q1 2026, filed 6 May 2026.